Compare MESH & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MESH | AUTL |
|---|---|---|
| Founded | 2025 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 427.8M | 431.2M |
| IPO Year | N/A | 2025 |
| Metric | MESH | AUTL |
|---|---|---|
| Price | $9.89 | $1.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 72.1K | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,120,000.00 |
| Revenue This Year | N/A | $669.62 |
| Revenue Next Year | N/A | $79.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 496.00 |
| 52 Week Low | $9.88 | $1.11 |
| 52 Week High | $9.94 | $2.70 |
| Indicator | MESH | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 49.42 | 40.70 |
| Support Level | $9.88 | $1.27 |
| Resistance Level | $9.91 | $1.52 |
| Average True Range (ATR) | 0.00 | 0.11 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 50.00 | 0.96 |
Meshflow Acquisition Corp is a blank check company.
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.